# Desmopressin Acetate 0.2 mg Tablets, Fasting

> **NCT00835211** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Desmopressin Acetate 0.2 mg Tablets
- **DRUG:** DDAVP® 0.2 mg Tablets

## Key facts

- **NCT ID:** NCT00835211
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2009-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00835211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00835211, "Desmopressin Acetate 0.2 mg Tablets, Fasting". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00835211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*